Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake-Reference-Cited by-同舟云学术

Relationship between plasma, atrial and ventricular perhexiline concentrations in humans: insights into factors affecting myocardial uptake

Published:2014-04-22 Issue:5 Volume:77 Page:789-795
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Drury Nigel E.¹²³,Licari Giovanni¹⁴,Chong Cher-Rin¹⁵,Howell Neil J.³,Frenneaux Michael P.⁶⁷,Horowitz John D.¹⁵,Pagano Domenico³,Sallustio Benedetta C.¹⁴

Affiliation:

1. Departments of Clinical Pharmacology and Cardiology; Basil Hetzel Institute; The Queen Elizabeth Hospital; Woodville SA Australia

2. The Discipline of Surgery; University of Adelaide; Adelaide SA Australia

3. Department of Cardiothoracic Surgery; Queen Elizabeth Hospital; Birmingham UK

4. The Discipline of Pharmacology; University of Adelaide; Adelaide SA Australia

5. The Discipline of Medicine; University of Adelaide; Adelaide SA Australia

6. School of Clinical & Experimental Medicine; University of Birmingham; Birmingham UK

7. School of Medicine; University of Aberdeen; Aberdeen UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12254/fullpdf

Reference19 articles.

1. Myocardial uptake of drugs and clinical effects;Horowitz;Clin Pharmacokinet,1986

2. Accumulation of drugs by resting or beating cardiac tissue;Lullmann;Eur J Pharmacol,1979

3. Efficacy and safety of perhexiline maleate in refractory angina. A double-blind placebo-controlled clinical trial of a novel antianginal agent;Cole;Circulation,1990

4. Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment;Lee;Circulation,2005

5. Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy;Abozguia;Circulation,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Antianginal Drug Perhexiline Displays Cytotoxicity against Colorectal Cancer Cells In Vitro: A Potential for Drug Repurposing;Cancers;2022-02-18

2. Hypertrophic Cardiomyopathy: From Phenotype and Pathogenesis to Treatment;Frontiers in Cardiovascular Medicine;2021-10-25

3. Enantioselectivity in the tissue distribution of perhexiline contributes to different effects on hepatic histology and peripheral neural function in rats;Pharmacology Research & Perspectives;2018-05-22

4. Pleiotropic mechanisms of action of perhexiline in heart failure;Expert Opinion on Therapeutic Patents;2016-07-25

5. Stereoselective handling of perhexiline: implications regarding accumulation within the human myocardium;European Journal of Clinical Pharmacology;2015-09-16